MeSH term
Frequency | Condition_Probility | Female | 4 | 0.0 |
Humans | 19 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Base Sequence | 3 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 12 | 4 | 1.0 |
DNA, Complementary | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Animals | 8 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Mice | 4 | 0.0 |
Protein Binding | 4 | 0.0 |
*Repressor Proteins | 2 | 0.0 |
*Zebrafish Proteins | 8 | 3.0 |
CpG Islands/*genetics | 2 | 2.0 |
Cell Line | 4 | 0.0 |
Immunoblotting | 2 | 0.0 |
Ligands | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Receptors, LDL/*metabolism | 2 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
*Trans-Activators | 3 | 0.0 |
Transfection | 3 | 0.0 |
Signal Transduction | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Male | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Cytoskeletal Proteins/*metabolism | 2 | 1.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 3 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Mutation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Cell Survival | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
